{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:26:51Z","timestamp":1793870811532,"version":"4.6.1"},"reference-count":126,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.semnephrol.2024.151515","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T07:31:49Z","timestamp":1717659109000},"page":"151515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Acute Kidney Injury and Subsequent Cardiovascular Disease: Epidemiology, Pathophysiology, and Treatment"],"prefix":"10.1016","volume":"44","author":[{"given":"Ming-Jen","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen D.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0001","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the Consensus Conference of the Acute Dialysis Quality Initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151515_bib0003","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1681\/ASN.2005101084","article-title":"Influence of acute renal failure on coronary vasoregulation in dogs","volume":"17","author":"Kingma","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0004","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.thromres.2017.01.004","article-title":"Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: a nationwide retrospective cohort study","volume":"151","author":"Kuo","year":"2017","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0005","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1681\/ASN.2014111114","article-title":"Elevated BP after AKI","volume":"27","author":"Hsu","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0006","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2215\/CJN.04110808","article-title":"Long-term prognosis of acute kidney injury after first acute stroke","volume":"4","author":"Tsagalis","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0007","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.kint.2020.06.032","article-title":"A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death","volume":"99","author":"Ikizler","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0008","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.kint.2023.08.005","article-title":"A comprehensive description of kidney disease progression after acute kidney injury from a prospective, parallel-group cohort study","volume":"104","author":"Horne","year":"2023","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0009","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.amjmed.2016.09.016","article-title":"30-day readmissions after an acute kidney injury hospitalization","volume":"130","author":"Silver","year":"2017","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2215\/CJN.12591117","article-title":"Acute kidney injury and risk of heart failure and atherosclerotic events","volume":"13","author":"Go","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0011","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2016010105","article-title":"AKI and long-term risk for cardiovascular events and mortality","volume":"28","author":"Odutayo","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CN108671","article-title":"Acute kidney injury (AKI) outcome, a predictor of long-term major adverse cardiovascular events (MACE)","volume":"85","author":"Omotoso","year":"2016","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0013","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.2013060610","article-title":"Long-term risk of coronary events after AKI","volume":"25","author":"Wu","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151515_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002475","article-title":"Impact of contrast-induced acute kidney injury after percutaneous coronary intervention on short- and long-term outcomes: pooled analysis from the HORIZONS-AMI and ACUITY trials","volume":"8","author":"Giacoppo","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000933","article-title":"The impact of acute kidney injury on the long-term risk of stroke","volume":"3","author":"Wu","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0016","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.ajkd.2017.08.027","article-title":"Acute kidney injury and risk of incident heart failure among US veterans","volume":"71","author":"Bansal","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0017","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1681\/ASN.2013121276","article-title":"Cardiovascular events after AKI: a new dimension","volume":"25","author":"Hsu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0018","series-title":"Critical Care Nephrology","first-page":"695","article-title":"Cardiorenal syndrome type 3","author":"Zachariah","year":"2019"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0019","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00134-017-4810-4","article-title":"The ten barriers for translation of animal data on AKI to the clinical setting","volume":"43","author":"Liu","year":"2017","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"Rabb","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0021","unstructured":"Goyal A, Daneshpajouhnejad P, Hashmi MF, Bashir K. Acute kidney injury. StatPearls; 2023. Updated February 19, 2023. Accessed August 9, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441896\/"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0022","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s13054-015-1163-7","article-title":"Fluid overload and acute kidney injury: cause or consequence?","volume":"19","author":"Ostermann","year":"2015","journal-title":"Crit Care"},{"issue":"12 suppl 1","key":"10.1016\/j.semnephrol.2024.151515_bib0023","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.amjmed.2006.09.012","article-title":"Pathophysiology of volume overload in acute heart failure syndromes","volume":"119","author":"Chen","year":"2006","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0024","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ehf2.13775","article-title":"Myocardial oedema: pathophysiological basis and implications for the failing heart","volume":"9","author":"Vasques-N\u00f3voa","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0025","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1152\/japplphysiol.00965.2006","article-title":"Acute volume overload elevates T-wave alternans magnitude","volume":"102","author":"Narayan","year":"2007","journal-title":"J Appl Physiol (1985)"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0026","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1540-8167.2010.01924.x","article-title":"Temporal associations between thoracic volume overload and malignant ventricular arrhythmias: a study of intrathoracic impedance","volume":"22","author":"Ip","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0027","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1152\/advan.00049.2009","article-title":"The renal renin-angiotensin system","volume":"33","author":"Harrison-Bernard","year":"2009","journal-title":"Adv Physiol Educ"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0028","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0022-3565(25)39403-6","article-title":"Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus","volume":"267","author":"Qadri","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0029","series-title":"Textbook of Cardiorenal Medicine","author":"McCullough","year":"2020"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2016.03.080","article-title":"The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure","volume":"226","author":"Rossi","year":"2017","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151515_bib0031","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1097\/HJH.0000000000003285","article-title":"Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway","volume":"40","author":"Lu","year":"2022","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0032","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1006\/jmcc.1996.0333","article-title":"Angiotensin II induces apoptosis of adult ventricular myocytes in vitro","volume":"29","author":"Kajstura","year":"1997","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0033","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.ATV.20.3.645","article-title":"Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress","volume":"20","author":"Pueyo","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151515_bib0034","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.CIR.100.11.1223","article-title":"Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis","volume":"100","author":"Tummala","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1523-1755.2001.059002415.x","article-title":"Transcription factor-kappa B (NF-kappa B) and renal disease","volume":"59","author":"Guijarro","year":"2001","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0036","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151515_bib0037","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1681\/ASN.2016101066","article-title":"Immunologic effects of the renin-angiotensin system","volume":"28","author":"Crowley","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0038","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0039","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jacbts.2019.06.005","article-title":"Acute kidney injury induces remote cardiac damage and dysfunction through the galectin-3 pathway","volume":"4","author":"Prud'homme","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","article-title":"The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications","volume":"29","author":"Miller","year":"2019","journal-title":"Clin Auton Res"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151515_bib0041","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ajh\/hpu066","article-title":"Actions of circulating angiotensin II and aldosterone in the brain contributing to hypertension","volume":"27","author":"Leenen","year":"2014","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0042","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"issue":"suppl E","key":"10.1016\/j.semnephrol.2024.151515_bib0043","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1093\/eurheartjsupp\/suac030","article-title":"Sympathetic activation in heart failure","volume":"24","author":"Gronda","year":"2022","journal-title":"Eur Heart J Suppl"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0044","doi-asserted-by":"crossref","first-page":"H190","DOI":"10.1152\/ajpheart.00622.2006","article-title":"Aldosterone impairs baroreflex sensitivity in healthy adults","volume":"292","author":"Monahan","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts","volume":"307","author":"Bristow","year":"1982","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0046","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1536\/ihj.17-313","article-title":"Catecholamine-induced senescence of endothelial cells and bone marrow cells promotes cardiac dysfunction in mice","volume":"59","author":"Katsuumi","year":"2018","journal-title":"Int Heart J"},{"issue":"17","key":"10.1016\/j.semnephrol.2024.151515_bib0047","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2017.08.056","article-title":"Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney","volume":"70","author":"Polhemus","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0048","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semnephrol.2018.10.007","article-title":"Kidney-immune system crosstalk in AKI","volume":"39","author":"Singbartl","year":"2019","journal-title":"Semin Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151515_bib0049","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2215\/CJN.07590714","article-title":"Cytokines: names and numbers you should care about","volume":"10","author":"Holdsworth","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151515_bib0050","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0051","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/01.ASN.0000064946.94590.46","article-title":"Distant effects of experimental renal ischemia\/reperfusion injury","volume":"14","author":"Kelly","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151515_bib0052","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11886-018-1067-7","article-title":"Tumor necrosis factor-\u03b1 in heart failure: an updated review","volume":"20","author":"Schumacher","year":"2018","journal-title":"Curr Cardiol Rep"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151515_bib0053","doi-asserted-by":"crossref","first-page":"H1025","DOI":"10.1152\/ajpheart.00795.2013","article-title":"Interleukin-18 mediates interleukin-1-induced cardiac dysfunction","volume":"306","author":"Toldo","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0054","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","article-title":"Regulation of the inflammatory response in cardiac repair","volume":"110","author":"Frangogiannis","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yjmcc.2019.04.025","article-title":"Cardiac arrhythmias after renal I\/R depend on IL-1\u03b2","volume":"131","author":"Alarcon","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0056","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cca.2014.10.041","article-title":"Biomarkers and physiopathology in the cardiorenal syndrome","volume":"443","author":"Bouquegneau","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0057","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2362.2010.02258.x","article-title":"From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology","volume":"40","author":"Bolignano","year":"2010","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151515_bib0058","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejvs.2016.01.009","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro","volume":"51","author":"Eilenberg","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0059","first-page":"5","article-title":"TWEAK-Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome","volume":"254","author":"Poveda","year":"2021","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0060","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbadis.2016.01.006","article-title":"NF\u03baBiz protein downregulation in acute kidney injury: modulation of inflammation and survival in tubular cells","volume":"1862","author":"Poveda","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0061","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1744-9987.2011.00966.x","article-title":"Serum TNF-related and weak inducer of apoptosis levels in septic shock patients","volume":"15","author":"Nagai","year":"2011","journal-title":"Ther Apher Dial"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151515_bib0062","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1681\/ASN.2010101073","article-title":"The inflammatory cytokines TWEAK and TNF\u03b1 reduce renal klotho expression through NF\u03baB","volume":"22","author":"Moreno","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0063","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/131950","article-title":"TNF-like weak inducer of apoptosis aggravates left ventricular dysfunction after myocardial infarction in mice","volume":"2014","author":"Jarr","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0064","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ki.2015.332","article-title":"The inflammatory cytokine TWEAK decreases PGC-1\u03b1 expression and mitochondrial function in acute kidney injury","volume":"89","author":"Ruiz-Andres","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0065","doi-asserted-by":"crossref","first-page":"e54054","DOI":"10.1371\/journal.pone.0054054","article-title":"PGC1\u03b1 plays a critical role in TWEAK-induced cardiac dysfunction","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS One"},{"issue":"1-4","key":"10.1016\/j.semnephrol.2024.151515_bib0066","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000363545","article-title":"Role of renal oxygenation and mitochondrial function in the pathophysiology of acute kidney injury","volume":"127","author":"Nourbakhsh","year":"2014","journal-title":"Nephron Clin Pract"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0067","doi-asserted-by":"crossref","first-page":"F589","DOI":"10.1152\/ajprenal.00372.2021","article-title":"Mitochondria as mediators of systemic inflammation and organ cross talk in acute kidney injury","volume":"322","author":"Hepokoski","year":"2022","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151515_bib0068","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"7397","key":"10.1016\/j.semnephrol.2024.151515_bib0069","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature10992","article-title":"Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure","volume":"485","author":"Oka","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-016-0241-x","article-title":"The level of free circulating mitochondrial DNA in blood as predictor of death in case of acute coronary syndrome","volume":"22","author":"Sudakov","year":"2017","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0071","first-page":"199","article-title":"Mitochondrial transcription factor A is a proinflammatory mediator in hemorrhagic shock","volume":"30","author":"Chaung","year":"2012","journal-title":"Int J Mol Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151515_bib0072","doi-asserted-by":"crossref","first-page":"H768","DOI":"10.1152\/ajpheart.00779.2014","article-title":"Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome","volume":"308","author":"Wenceslau","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151515_bib0073","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1681\/ASN.2014080750","article-title":"Regulation of mitochondrial dynamics by dynamin-related protein-1 in acute cardiorenal syndrome","volume":"26","author":"Sumida","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0074","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12906-021-03270-w","article-title":"Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia-reperfusion injury in obese rats","volume":"21","author":"Tai","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.redox.2015.09.005","article-title":"Reactive oxygen species and mitochondria: a nexus of cellular homeostasis","volume":"6","author":"Dunn","year":"2015","journal-title":"Redox Biol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151515_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0077","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1605358","article-title":"Characterization of the oxidative stress in renal ischemia\/reperfusion-induced cardiorenal syndrome type 3","volume":"2020","author":"Caio-Silva","year":"2020","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0078","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/cvr\/cvz331","article-title":"NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload","volume":"117","author":"Schnelle","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151515_bib0079","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NF\u03baB signaling pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0080","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.RES.66.3.622","article-title":"Effects of intracellular acidosis on [Ca2+]i transients, transsarcolemmal Ca2+ fluxes, and contraction in ventricular myocytes","volume":"66","author":"Kohmoto","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0081","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2013.04.008","article-title":"H\u207a-activated Na\u207a influx in the ventricular myocyte couples Ca\u00b2\u207a-signalling to intracellular pH","volume":"61","author":"Garciarena","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.semnephrol.2024.151515_bib0082","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-41588-3_8","article-title":"Proton modulation of cardiac I Na: a potential arrhythmogenic trigger","volume":"221","author":"Jones","year":"2014","journal-title":"Handb Exp Pharmacol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151515_bib0083","doi-asserted-by":"crossref","first-page":"H1680","DOI":"10.1152\/ajpheart.00070.2013","article-title":"Modulation of ventricular transient outward K\u207a current by acidosis and its effects on excitation-contraction coupling","volume":"304","author":"Saegusa","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0084","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-201X.1997.00263.x","article-title":"pH and smooth muscle","volume":"161","author":"Aalkjaer","year":"1997","journal-title":"Acta Physiol Scand"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0085","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/cc13173","article-title":"Effects of clinically relevant acute hypercapnic and metabolic acidosis on the cardiovascular system: an experimental porcine study","volume":"17","author":"Stengl","year":"2013","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0086","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13613-019-0509-8","article-title":"Management of hyperkalemia in the acutely ill patient","volume":"9","author":"D\u00e9pret","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0087","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ki.2013.150","article-title":"Plasma FGF23 levels increase rapidly after acute kidney injury","volume":"84","author":"Christov","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0088","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semnephrol.2018.10.005","article-title":"Fibroblast growth factor 23 and klotho in AKI","volume":"39","author":"Christov","year":"2019","journal-title":"Semin Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151515_bib0089","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2010.328","article-title":"Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective","volume":"78","author":"Hu","year":"2010","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MNH.0000000000000231","article-title":"The role of fibroblast growth factor 23 and klotho in uremic cardiomyopathy","volume":"25","author":"Grabner","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"84","key":"10.1016\/j.semnephrol.2024.151515_bib0091","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1046\/j.1523-1755.63.s84.9.x","article-title":"Nitric oxide in uremia: effects of several potentially toxic guanidino compounds","author":"De Deyn","year":"2003","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0092","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0022-2828(73)90068-0","article-title":"The effects of uremic compounds on cardiac function and metabolism","volume":"5","author":"Scheuer","year":"1973","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0093","first-page":"367","article-title":"Negative inotropic effects of phenol on isolated cardiac muscle","volume":"102","author":"Lee","year":"1981","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151515_bib0094","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1681\/ASN.2018060609","article-title":"Indoxyl sulfate and p-cresyl sulfate promote vascular calcification and associate with glucose intolerance","volume":"30","author":"Opdebeeck","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0096","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000362090","article-title":"Impact of chronic kidney disease on myocardial blood flow regulation in dogs","volume":"126","author":"Kingma","year":"2014","journal-title":"Nephron Exp Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0097","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11255-018-2056-x","article-title":"Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury","volume":"51","author":"Veldeman","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151515_bib0098","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.2012.451","article-title":"Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors","volume":"83","author":"Harel","year":"2013","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.semnephrol.2024.151515_bib0099","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jval.2020.01.024","article-title":"Nephrologist follow-up care of patients with acute kidney disease improves outcomes: Taiwan experience","volume":"23","author":"Wu","year":"2020","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0100","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1053\/j.ajkd.2020.03.023","article-title":"NSAIDs in CKD: are they safe?","volume":"76","author":"Baker","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"9894","key":"10.1016\/j.semnephrol.2024.151515_bib0101","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151515_bib0102","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2022.100034","article-title":"Optimal perfusion targets in cardiogenic shock","volume":"1","author":"Mathew","year":"2022","journal-title":"JACC Adv"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0104","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s13054-021-03813-0","article-title":"Equilibrating SSC guidelines with individualized care","volume":"25","author":"Vincent","year":"2021","journal-title":"Crit Care"},{"issue":"17","key":"10.1016\/j.semnephrol.2024.151515_bib0105","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0106","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12882-021-02480-1","article-title":"Achieved blood pressure post-acute kidney injury and risk of adverse outcomes after AKI: a prospective parallel cohort study","volume":"22","author":"McCoy","year":"2021","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151515_bib0107","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0108","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ki.2009.159","article-title":"Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury","volume":"76","author":"Bouchard","year":"2009","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0109","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2016.08.027","article-title":"Diuretic resistance","volume":"69","author":"Hoorn","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"48","key":"10.1016\/j.semnephrol.2024.151515_bib0110","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/ehu320","article-title":"Terminology and definition of changes renal function in heart failure","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.semnephrol.2024.151515_bib0111","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","article-title":"Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury","volume":"137","author":"Ahmad","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0112","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1164\/rccm.201706-1255OC","article-title":"Timing of renal support and outcome of septic shock and acute respiratory distress syndrome. A post hoc analysis of the AKIKI randomized clinical trial","volume":"198","author":"Gaudry","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"10.1016\/j.semnephrol.2024.151515_bib0113","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","article-title":"Timing of renal-replacement therapy in patients with acute kidney injury and sepsis","volume":"379","author":"Barbar","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151515_bib0114","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa2000741","article-title":"Timing of initiation of renal-replacement therapy in acute kidney injury","volume":"383","author":"Bagshaw","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13054-022-04120-y","article-title":"A Bayesian reanalysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury (STARRT-AKI) trial","volume":"26","author":"Zampieri","year":"2022","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0116","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2215\/CJN.05800519","article-title":"Renin-angiotensin system blockade after acute kidney injury (AKI) and risk of recurrent AKI","volume":"15","author":"Hsu","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151515_bib0117","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00134-018-5160-6","article-title":"Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury","volume":"44","author":"Gayat","year":"2018","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151515_bib0118","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jamainternmed.2018.4749","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury","volume":"178","author":"Brar","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.semnephrol.2024.151515_bib0119","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.semnephrol.2024.151515_bib0120","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.semnephrol.2024.151515_bib0121","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151515_bib0122","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151515_bib0123","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11892-021-01442-z","article-title":"Renal protection with SGLT2 inhibitors: effects in acute and chronic kidney disease","volume":"22","author":"Bailey","year":"2022","journal-title":"Curr Diab Rep"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151515_bib0124","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2020.03.019","article-title":"Acute kidney injury events in patients with type 2 diabetes using SGLT2 inhibitors versus other glucose-lowering drugs: a retrospective cohort study","volume":"76","author":"Rampersad","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151515_bib0125","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc17-1011","article-title":"Acute kidney injury in patients on SGLT2 inhibitors: a propensity-matched analysis","volume":"40","author":"Nadkarni","year":"2017","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151515_bib0126","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/dom.13754","article-title":"Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials","volume":"21","author":"Gilbert","year":"2019","journal-title":"Diabetes Obes Metab"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T10:51:58Z","timestamp":1748343118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929524000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":126,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0270929524000354"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151515","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Kidney Injury and Subsequent Cardiovascular Disease: Epidemiology, Pathophysiology, and Treatment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151515"}}